Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Mesenchymal Stem Cell Conditioned Medium for Diabetes and Diabetic Complications
jRCT1051260123Recruiting
- Sponsor
- Heiwa Clinic
- Start
- Apr 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM) and diabetes complications, sponsored by Heiwa Clinic. Primary endpoints: Change in glycemic control parameters, Change in renal function and 3 more. Started Apr 2024; status: recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)diabetes complications
Beyond the preview
Go deeper on jRCT1051260123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260123.